...
首页> 外文期刊>Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics >Identification of serum component involved in generation of neo-lectin with agglutinating and phenoloxidase activities in human serum
【24h】

Identification of serum component involved in generation of neo-lectin with agglutinating and phenoloxidase activities in human serum

机译:鉴定人血清中具有凝集和酚氧化酶活性的新凝集素生成过程中涉及的血清成分

获取原文
获取原文并翻译 | 示例
           

摘要

Human serum albumin (HSA) was identified as the component involved in generation of neo-lectin molecules with both lectin and phenoloxidase activities. Pronase treated HSA was able to agglutinate hen RBC and oxidize hydroquinone. Sodium dodecyl sulphate (SDS) treated HSA agglutinated both hen and sheep RBC as well as oxidized dopamine. The hemagglutinating activities of pronase/SDS treated HSA observed against hen RBC were dosimetric. The oxidation of pronase/SDS treated HSA with hydroquinone/dopamine, respectively, was inhibitable by inhibitors of phenoloxidase, namely, phenylthiourea and tropolone. Very low concentrations of HSA could generate these humoral neo-lectin molecules.
机译:人血清白蛋白(HSA)被确定为涉及具有凝集素和酚氧化酶活性的新凝集素分子生成的成分。链酶处理的HSA能够凝结RBC并氧化对苯二酚。十二烷基硫酸钠(SDS)处理的HSA会凝结母鸡和绵羊的RBC以及氧化的多巴胺。链淀粉酶/ SDS处理的HSA对母鸡RBC的血凝活性是剂量学的。苯醌/多巴胺分别用苯醌/多巴胺对脯氨酸酶/ SDS处理的HSA的氧化可被酚氧化酶抑制剂苯硫脲和托酚酮抑制。极低浓度的HSA可能产生这些体液新凝集素分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号